Calendar Inhibikase Therapeutics, Inc.

Equities

IKT

US45719W2052

Market Closed - Nasdaq 16:30:01 2024-05-03 EDT 5-day change 1st Jan Change
1.39 USD +3.73% Intraday chart for Inhibikase Therapeutics, Inc. -18.71% +9.45%

Chart calendar Inhibikase Therapeutics, Inc.

90c748698020eea53f.EQTIDhogRI7fbS-x9Xch1FBs12IwyUcEkg5Wg4Hz85k.TmeMOG0NJsvpAn7zpShgnBcDjlsHmjRNokMQscqrpuB6W_15WGV34OwJHw~4bed5393c1d39b01dbb630430919f030

Upcoming events on Inhibikase Therapeutics, Inc.

2024-05-12 Q1 2024 Earnings Release (Projected)
2024-08-11 Q2 2024 Earnings Release (Projected)
2024-11-10 Q3 2024 Earnings Release (Projected)

Past events on Inhibikase Therapeutics, Inc.

2024-04-04 U.S. Food and Drug Administration Pre IND Meeting
2024-03-28 08:00 Q4 2023 Earnings Call
2024-03-27 16:15 Q4 2023 Earnings Release
2024-03-09 13:25 AD/PD Alzheimers and Parkinsons Diseases Conference
2023-11-15 08:00 Q3 2023 Earnings Call
2023-11-14 16:30 Q3 2023 Earnings Release
2023-09-11 H.C. Wainwright Global Investment Conference
2023-08-29 07:45 Parkinson Disease and Movement Disorders International Congress - Abstract No: 155
2023-08-28 07:45 Parkinson Disease and Movement Disorders International Congress - Abstract No: 1444
2023-08-15 08:00 Q2 2023 Earnings Call
2023-08-14 16:20 Q2 2023 Earnings Release
2023-06-23 09:30 Annual General Meeting
2023-06-06 15:00 LD Micro Invitational Conference
2023-05-16 08:00 Q1 2023 Earnings Call
2023-05-15 08:30 Q1 2023 Earnings Release
2023-05-11 13:45 Sidoti Micro-Cap Virtual Conference
2023-05-04 Annual General Meeting
2023-04-26 16:00 Planet MicroCap Showcase
2023-04-25 American Academy of Neurology Meeting
2023-04-03 08:00 Q4 2022 Earnings Call

Annual results

Fiscal PeriodDecember 2020 2022 2023 2024
Net sales
Million USD
Released
Forecast
Spread
0,70


0,00


0,26
0,26
-0.19%

0,00

EBITDA
Released
Forecast
Spread
0,00


0,00


0,00
0,00
-

0,00

EBIT
Million USD
Released
Forecast
Spread
0,00


0,00


-20,1
-20,6
2.51%

-23,8

Earnings before Tax (EBT)
Million USD
Released
Forecast
Spread
0,00


0,00


-19,0
-19,7
3.64%

-23,8

Net income
Million USD
Released
Forecast
Spread
0,00


-18,1


-19,0
-19,7
3.42%

-23,8

EPS
USD
Released
Forecast
Spread
-2,10


-4,32


-3,57
-2,76
-29.58%

-1,78

Announcement Date31/03/2131/03/2327/03/24-

Quarterly results

Fiscal PeriodDecember 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4
Net sales
Million USD
Released
Forecast
Spread
0,06
0,00
-
0,12
0,00
-
0,08
0,00
-
0,00
0,00
-

0,00


0,00


0,00


0,00

EBIT
Million USD
Released
Forecast
Spread
-4,71
-4,46
-5.76%
-6,20
-5,04
-23.16%
-4,77
-6,36
25.01%
-4,40
-4,92
10.51%

-5,00


-5,06


-5,16


-5,27

Earnings before Tax (EBT)
Million USD
Released
Forecast
Spread









-4,18
-4,90
14.68%












Net income
Million USD
Released
Forecast
Spread
-4,48
-4,41
-1.56%
-5,78
-4,77
-21.11%
-4,60
-6,01
23.59%
-4,18
-4,85
13.88%

-4,89


-5,00


-5,03


-5,17

EPS
USD
Released
Forecast
Spread
-0,96
-0,90
-6.67%
-1,11
-0,92
-20.65%
-0,86
-1,12
23.21%
-0,64
-0,85
24.71%

-0,79


-0,37


-0,37


-0,38

Announcement Date15/05/2314/08/2314/11/2327/03/24----

Net sales - Quarter - Rate of surprise

Quarterly earnings - Rate of surprise

Net sales - Annual - Rate of surprise

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. IKT Stock
  4. Calendar Inhibikase Therapeutics, Inc.